Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 19, 2025 $691.54 -0.93% $703.21 X 98.34% 0
Aug 19, 2025 Bullish $703.21 V 1
Aug 18, 2025 $690.45 -1.54% $698.05 V 98.91% 2
Aug 18, 2025 $694.50 -0.96% $698.05 V 99.49% 4
Aug 18, 2025 Bullish $698.05 X 0
Aug 14, 2025 $650.44 +1.72% $684.43 V 95.03% 1
Aug 14, 2025 $646.31 +1.08% $684.43 V 94.43% 1
Aug 14, 2025 $706.32 +10.46% $684.43 V 96.80% 1
Aug 12, 2025 $646.55 +1.78% $639.43 V 98.89% 2
Aug 12, 2025 $642.30 +1.12% $639.43 V 99.55% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE